Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SMMT stock hub

Summit Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SMMTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SMMT

In the news

Latest news · SMMT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-271

P25 -105.6P50 -46.5P75 -3.1

ROIC-166.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SMMT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001599298
Company name	Summit Therapeutics Inc.
Country	United States
Country code	US
Cusip	86627T108
Employees	265
Employees Change	106%
Employees Change Percent	66.67
Enterprise value	$13.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US86627T1088
Last refreshed	2026-05-10
Market cap	$14B
Market cap category	Large-Cap
Price	$18.08
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	SMMT
Website	https://www.smmttx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.59%
EV Sales Forward	459.18x
FCF yield	-2.74%
P/B ratio	25.7x
PS Forward	478.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-1.2B
Net Income Growth Years	0%
Profit Per Employee	$-4.6M
ROA	-148.2
Roa5y	-45.9
ROCE	-216.6
ROE	-271
Roe5y	-217.4
ROIC	-166.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.75%
Cagr1y	-25.58%
Cagr3y	102.7%
Cagr5y	25.45%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$647.9M
Cash	$598.7M
Current Assets	$616.6M
Current Liabilities	$83.3M
Debt	$20M
Debt Equity	$0.04
Equity	$545.9M
Liabilities	$101.9M
Long Term Assets	$31.3M
Long Term Liabilities	$18.7M
Net Cash	$578.7M
Net Cash By Market Cap	$4.12
Net Cash Growth	63.07%
Net Debt Equity	$-1.06
Tangible Book Value	$544M
Tangible Book Value Per Share	$0.7
WACC	-2.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.41
Net Working Capital	$-62.2M
Quick ratio	7.19
Working Capital	$533.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.05%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	110.97%
1Y total return	-25.57%
200-day SMA	19.48
3Y total return	733.18%
50-day SMA	18.52
50-day SMA vs 200-day SMA	50under200
5Y total return	210.65%
All Time High	36.91
All Time High Change	-51.02%
All Time High Date	2025-04-24
All Time Low	0.66
All Time Low Change	2,639.39%
All Time Low Date	2022-12-02
ATR	1.64
Beta	-1.26
Beta1y	1.37
Beta2y	2.63
Ch YTD	3.37
High	18.15
High52	30.98
High52 Date	2025-08-05
High52ch	-41.64%
Low	17.06
Low52	13.83
Low52 Date	2026-02-05
Low52ch	30.73%
Ma50ch	-2.39%
Premarket Change Percent	2.33
Premarket Price	$17.55
Premarket Volume	16,679
Price vs 200-day SMA	-7.18%
RSI	44.16
RSI Monthly	52.79
RSI Weekly	49.46
Sharpe ratio	0.02x
Sortino ratio	0.09
Total Return	-4.05%
Tr YTD	3.37
Tr1m	-5.93%
Tr1w	12.19%
Tr3m	20.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	4
Analyst Price Target Top	$22.75
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.23
Earnings Revenue Estimate	40,850x
Operating Income	$-1.2B
Price target	$30.54
Price Target Change	$68.92
Price Target Change Top	$25.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	134,667,343%
Float Percent	17.35%
Shares Insiders	78.51%
Shares Institutions	15.26%
Shares Out	776,162,645
Shares Qo Q	1.18%
Shares Yo Y	4.05%
Short Ratio	13.27
Short Shares	25.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.2B
Average Volume	5,234,317.25x
Bv Per Share	0.7
CAPEX	$-480,000
Ch10y	111
Ch1m	-5.93
Ch1w	12.19
Ch1y	-25.57
Ch3m	20.61
Ch3y	733.2
Ch5y	210.7
Ch6m	-0.55
Change	5.42%
Change From Open	3.55
Close	17.15
Days Gap	1.81
Depreciation Amortization	165,000
Dollar Volume	70,130,819.4
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-1.2B
EBITDA	$-1.2B
EPS	$-1.59
F Score	1
FCF	$-384.5M
FCF EV Yield	-2.86x
FCF Per Share	$-0.5
Financing CF	613,653,000
Fiscal Year End	December
Founded	2,003
Goodwill	1,965,000
Investing CF	-334,658,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-23
Ma150	18.03
Ma150ch	0.28%
Ma20	21.07
Ma20ch	-14.19%
Net CF	-105,013,000
Next Earnings Date	2026-08-10
Open	17.46
Optionable	Yes
Position In Range	93.58
Post Close	18.08
Postmarket Change Percent	-1.55
Postmarket Price	$17.8
Ppne	21,062,000
Pre Close	17.15
Price Date	2026-05-08
Ptbv Ratio	25.8
Relative Volume	0.74x
Share Based Comp	794,115,000
Tr6m	-0.55%
Us State	Florida
Volume	3,878,917

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SMMT pay a dividend?

Capital-return profile for this ticker.

Performance

SMMT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SMMT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Float: +17.4% of shares outstanding

Insider ownership

+78.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SMMT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.2

Neutral momentum band

Price vs 200-day MA

-7.2%

50/200-day relationship not available

Beta (5Y)

-1.26

Less volatile than the market

Sharpe ratio

0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SMMT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SMMT stock rating?

Summit Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SMMT analysis?

The full report lives at /stocks/SMMT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SMMT?

The latest report frames SMMT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SMMT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.